Search research articles
Contact Us
Filters
Showing results (1-10 of 49) with videos related to
Page
of 5
Sort By:
Expert Opinion on Therapeutic Targets
|
September 23, 2003
Nuclear receptors as drug targets: new developments in coregulators, orphan receptors and major therapeutic areas
Frances M Sladek
Cell Cycle (Georgetown, Tex.)
|
August 17, 2012
The yin and yang of proliferation and differentiation: cyclin D1 inhibits differentiation factors ChREBP and HNF4α
Frances M Sladek
Molecular and Cellular Endocrinology
|
July 10, 2010
What are nuclear receptor ligands?
Frances M Sladek
Frontiers in Endocrinology
|
October 10, 2024
Editorial: Hepatocyte nuclear factor 4 alpha - new insights into an old receptor
Frances M Sladek, Udayan Apte, Poonamjot Deol
Molecular Endocrinology (Baltimore, Md.)
|
September 22, 2007
Nuclear receptor hepatocyte nuclear factor 4alpha1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter
Wendy W Hwang-Verslues, Frances M Sladek
Current Opinion in Pharmacology
|
September 14, 2010
HNF4α--role in drug metabolism and potential drug target?
Wendy W Hwang-Verslues, Frances M Sladek
Biomarkers in Medicine
|
June 27, 2012
HNF4α: a new biomarker in colon cancer?
Karthikeyani Chellappa, Graham R Robertson, Frances M Sladek
Bioinformatics (Oxford, England)
|
October 19, 2002
Identifying transcription factor binding sites through Markov chain optimization
Kyle Ellrott, Chuhu Yang, Frances M Sladek, et al.
Molecular and Cellular Biology
|
February 28, 2002
Competitive cofactor recruitment by orphan receptor hepatocyte nuclear factor 4alpha1: modulation by the F domain
Michael D Ruse, Martin L Privalsky, Frances M Sladek
The Journal of Biological Chemistry
|
September 3, 2002
Developmentally regulated N-terminal variants of the nuclear receptor hepatocyte nuclear factor 4alpha mediate multiple interactions through coactivator and corepressor-histone deacetylase complexes
Maria Elena Torres-Padilla, Frances M Sladek, Mary C Weiss
Page
of 5
Search research articles
Search
Showing results (1-10 of 49) with videos related to
Sort By:
Page
of 5
Expert Opinion on Therapeutic Targets
|
September 23, 2003
Nuclear receptors as drug targets: new developments in coregulators, orphan receptors and major therapeutic areas
Frances M Sladek
Cell Cycle (Georgetown, Tex.)
|
August 17, 2012
The yin and yang of proliferation and differentiation: cyclin D1 inhibits differentiation factors ChREBP and HNF4α
Frances M Sladek
Molecular and Cellular Endocrinology
|
July 10, 2010
What are nuclear receptor ligands?
Frances M Sladek
Frontiers in Endocrinology
|
October 10, 2024
Editorial: Hepatocyte nuclear factor 4 alpha - new insights into an old receptor
Frances M Sladek, Udayan Apte, Poonamjot Deol
Molecular Endocrinology (Baltimore, Md.)
|
September 22, 2007
Nuclear receptor hepatocyte nuclear factor 4alpha1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter
Wendy W Hwang-Verslues, Frances M Sladek
Current Opinion in Pharmacology
|
September 14, 2010
HNF4α--role in drug metabolism and potential drug target?
Wendy W Hwang-Verslues, Frances M Sladek
Biomarkers in Medicine
|
June 27, 2012
HNF4α: a new biomarker in colon cancer?
Karthikeyani Chellappa, Graham R Robertson, Frances M Sladek
Bioinformatics (Oxford, England)
|
October 19, 2002
Identifying transcription factor binding sites through Markov chain optimization
Kyle Ellrott, Chuhu Yang, Frances M Sladek, et al.
Molecular and Cellular Biology
|
February 28, 2002
Competitive cofactor recruitment by orphan receptor hepatocyte nuclear factor 4alpha1: modulation by the F domain
Michael D Ruse, Martin L Privalsky, Frances M Sladek
The Journal of Biological Chemistry
|
September 3, 2002
Developmentally regulated N-terminal variants of the nuclear receptor hepatocyte nuclear factor 4alpha mediate multiple interactions through coactivator and corepressor-histone deacetylase complexes
Maria Elena Torres-Padilla, Frances M Sladek, Mary C Weiss
Page
of 5